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Abstract: The classic cell culture involves the use of support in two dimensions, such as a well plate
or a Petri dish, that allows the culture of different types of cells. However, this technique does not
mimic the natural microenvironment where the cells are exposed to. To solve that, three-dimensional
bioprinting techniques were implemented, which involves the use of biopolymers and/or synthetic
materials and cells. Because of a lack of information between data sources, the objective of this review
paper is, to sum up, all the available information on the topic of bioprinting and to help researchers
with the problematics with 3D bioprinters, such as the 3D-Bioplotter™. The 3D-Bioplotter™ has
been used in the pre-clinical field since 2000 and could allow the printing of more than one material
at the same time, and therefore to increase the complexity of the 3D structure manufactured. It is
also very precise with maximum flexibility and a user-friendly and stable software that allows the
optimization of the bioprinting process on the technological point of view. Different applications
have resulted from the research on this field, mainly focused on regenerative medicine, but the lack
of information and/or the possible misunderstandings between papers makes the reproducibility
of the tests difficult. Nowadays, the 3D Bioprinting is evolving into another technology called 4D
Bioprinting, which promises to be the next step in the bioprinting field and might promote great
applications in the future.
Keywords: 3D printing; biopolymers; bioprinting
1. Introduction
Three-dimensional (3D) printing, also called Rapid Prototyping (RP), was originally developed
by Charles Hull in 1986 as a technique called stereolithography (SLA) [1,2]. For being the first 3D
technology ever conceived, its precision and resolution were and are still high [3].
The first technology was stereolithography, which consists of the solidification of a photosensitive
material by an ultraviolet light source [4]. Later, other 3D printing techniques were conceived such as
fused deposition modelling (FDM) [5], inkjet printing, direct laser patterning, cell-sheet technology,
cell-laden technology, extrusion-based printing [6], valve-based technology, acoustic printing [7],
selective laser melting [8], selective laser sintering [9], and laminated object manufacturing [10]. Some
of these technologies can be seen in Figure 1. All of them can also be classified into four different
categories, like extrusion printing, material sintering, material binding, and lamination [11].
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Figure 1. Examples of the available techniques in the 3D printing field [12].
Those technologies were first applied in the 3D printing field, but, 17 years ago, a new field
was introduced called 3D Bioprinting, and the first application was the development of vascular
tissue networks to maintain the cells within culture [13]. In addition, another application was the
production of synthetic biocompatible supports for cells, also called scaffolds, to mimic the natural
cellular microenvironment [14]. Several conditions must be accomplished before bioprinting, such as
the acquisition of a 3D image, a computer-aided design (CAD) software [15], and the ability to control
the deposition of the materials used [16].
Different approaches can be used to bioprint, either with or without cells at the initial step [12].
In particular, 80% of printers are optimized for an extrusion-based printing [17]. The material extrusion,
especially of thermoplastic materials, is the most common and inexpensive technique because it can
use a wide range of materials like polylactic acid (PLA), polycaprolactone (PCL), polyvinyl alcohol
(PVA), and biodegradable calcium phosphate glass, which are then combined with cells such as human
monocytes, for example to study the inflammation process [18]. On the other hand, the bioprinting
technique can use cells directly so the design of a proper structure for the accommodation of cells in
the synthesized scaffolds is more complicated but offers some advantages such as the possibility to
optimize the cell deposition and distribution, and the printing speed [11]. Thus, the main difference
between a typical material extrusion and a bioprinting technique is that the first one does not use cells
directly, so it requires a post-seeding process that might not be required for bioprinting techniques.
As previously mentioned, the bioprinting process can be performed using two different approaches,
called pre-seeding and post-seeding [19]. The pre-seeding bioprinting is a type of 3D bioprinting that
involves the printing of both materials and cells at the same time. Although it requires more time to
properly optimize the geometry of the scaffold manufactured, it also provides high applicability and
efficiency. On the other hand, the post-seeding process, which could be used after an extrusion-based
printing, consists of first printing the material and then co-culturing it with the proper cells. In this
review paper, those techniques are related to the step in which the extrusion material and the cells are
combined, as it could be at the same time for direct bioprinting, or after the printing of the material
(i.e., mold or sacrificial structure) for indirect bioprinting. Compared to the direct bioprinting, the
indirect one has lower efficiency. To sum up, direct bioprinting is more time-consuming than indirect
bioprinting, but it also has higher efficiency on cell deposition and might also be a way to increase cell
viability within the scaffold designed by not exposing cells under more stress.
In that context, several combinations of materials and cells, also called bio-inks, can be used to
perform direct bioprinting by combining materials such as microcarriers, decellularized extracellular
matrixes (dECM), and hydrogels with cells from tissue spheroids, cell pellets, and tissue strands [20].
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Specifically, hydrogels have some interesting properties because they are in a solid/aqueous state.
They are easily controllable by changing temperature and humidity [21], biodegradable, biocompatible,
with tailorable mechanical strength, and readily available [17]. Their limits are related to the dissolution
kinetics in body fluids and the difficult sterilization process. Of course, other materials can be used
to avoid these limitations such as metals and metal alloys, ceramics and carbon compounds, and
composites [11].
The most important bioprinting limitations are connected with the need of a vascular network to
maintain cell viability within the bioprinted tissue or organ [7], the presence of bottlenecks between
biology and engineering to bioprint complex compositions [22,23], the complexity of native tissues [24],
the viscosity of the material [25–27], and, finally, the bio-inks available on the market. An ideal bio-ink
must be strongly biocompatible, with appropriate rheological parameters [15,28], architectural integrity,
and assure an equilibrium between cell viability and functionality after bioprinting [29].
In this review, we will focus on applications of 3D bio-printers available on the market, mainly the
3D-Bioplotter™ systems, for both direct and indirect bioprinting. We will be focused on 3D-Bioplotter™
systems because of their precision, flexibility, and user-friendly employment. These printers also
offer the possibility of a process optimization in relation to the effects of the parameters and their
interdependence with a stable platform that leads to a higher replicability of the results compared to
other bioprinters available on the market. Moreover, we will refer to the state of the art on bioprinting,
what has been done, and what will be needed for future studies.
2. Materials for Bioprinting
2.1. Polymers
2.1.1. Natural Polymers
Natural polymers, also called biopolymers, have different properties and advantages, related to
their chemical-physical compositions that can be adjusted to the target tissue and cell types [30–32].
If the scaffolds are properly planned, cells can have enough space for cell proliferation and
migration [33]. Rheological parameters also need to be considered because they have high relevancy
for the biofabrication process. Some of those parameters are the viscosity, shear-thinning, yield
stress, and porosity, among others [34]. The use of biopolymers allows a better mimicry of the
natural microenvironment of cells but have reproducibility problems of experiments because of their
batch-to-batch variability.
Nowadays, bioprinting uses many natural and semi-synthetic polymers, such as collagen
and fibrinogen [35,36], gelatin methacrylamide (GelMA) [34,37], alginate [38,39], Matrigel™ and
Cultrex® [40], and basement membranes (ECM containing proteins like fibronectin, laminin, and
collagen type IV) [41,42]. Other strategies can include the acquisition of ECM by inducing it to a
chondrocyte culture and then separating it from the cells by a devitalized technique [43].
2.1.2. Synthetic Polymers
Internal variations on natural polymer synthesis make the comparison between experiments
difficult. Synthetic polymers solve that problem because they have an exact structure and composition
between samples.
Some of the materials that are used might be polycaprolactone (PCL), polyethylene glycol and
derivatives (PEG), polylactic acid (PLA), poly(lactic-co-glycolic acid) (PLGA) [44,45], and peptide
scaffolds of BD™ Pura Matrix™ [41,46].
2.2. Cross-Linking Methods
Different cross-linking methods can be employed to retain certain geometries of the materials
used for bioprinting, such as chemical, light, physical, and hybrid techniques. As seen in Figure 2,
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each material used is classified according to the type of cross-linking method used. As for the chemical
cross-linking, the majority of the articles use alginate as the main material (80%) followed by alginate:
gelatin (15%) and PEG-polymers (5%). In relation to the light techniques, the majority of the articles
report the use of methacrylated-gelatin (55.6%), followed by methacrylated hyaluronic acid (33.3%),
and hydroxyapatite (11.1%) as main materials of the hydrogels. Concerning the hybrid techniques, for
the combination of more than one technique, the majority of the authors use methacrylated-gelatin
(75%) or alginate (25%). Respecting the physical techniques, by the use of temperature, for example, the
majority of the articles report as main material lignin combined with HPU (50%) or decellularized ECM
(50%). Finally, a small part of the articles does not specify the cross-linking method used, and the main
materials used for their hydrogels are alginate (40%), alginate: gelatin (40%) or methacrylated-gelatin
(20%). Some examples of each category could be, for the chemical methods, the use of calcium ion
solution, for light techniques, the exposure to a UV light source, physical cross-linking by temperature
and hybrid techniques, by using more than one technique at the same time.
Figure 2. Description of the cross-linking techniques and their materials used for the 3D-Bioplotter™
bioprinter. The information is represented as percentages (%) and the different materials used are
represented by colors.
2.3. Cellular Typologies
In this section, the most important cell types that are being used with different types of 3D
bioprinters, and with the 3D-Bioplotter™ will be described. All of the available information will be
distributed in subsections according to the type of cells used.
2.3.1. Vascular Tissues
Vascularization is very important for the bioprinting, especially for large tissue constructs, because
cells need a constant supply of nutrients and oxygen [12]. According to analyzed literature, one of the
strategies is the use of the HUVEC cell line to develop vascular networks for cell viability maintenance,
as seen in Table 1.
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Table 1. Principal vascular tissue applications.
3D Printer Used Cell Line (s) Used Materials Used Application Reference
Modified thermal
inkjet printer from
HP® and Canon®
Not specified
Sacrificial material
(carbohydrate glass
filament networks)
Microvascular
networks [47,48]
3D-Bioplotter™ HUVEC 1
Gelatin ink completed
with PEG-SVA
Cell-compatible
hydrogels [49]
3D-Bioplotter™ HUVEC and HWA 2
Methacrylated gelatin,
methacrylated
hyaluronic acid, and
PEG-4A 3
Robust cryogel
for adipose tissue
engineering
[50]
1 human umbilical vein endothelial cells. 2 human adipose progenitor cell line. 3 polyethylene glycol-valeric acid.
It seems that the presence of a PEG-derived polymer within the hydrogel is needed for the
establishment of a proper vascular network for cell viability preservation. Because there is a lack of
information on the cell line used with a modified thermal inkjet printer, we cannot confirm that the use
of a sacrificial material like carbohydrate glass filament networks could be a better alternative than
using PEG-derived polymers for microvascular network synthesis.
2.3.2. Cartilage and Bone-Like Structures
Many cartilage and bone applications can be reflected in Table 2, by 3D-Bioplotter™ and
other 3D bioprinting machines. For cartilage tissue engineering, the majority of the cells used are
related to primary chondrocytes followed by one example of human chondrocytes [51]. For bone
tissue engineering, there are only two examples in the table, by using bone marrow stromal cells
(BMSCs) combined with different hydrogels and endothelial stromal cells derived from the stromal
vascular fraction of adipose tissue (SVFCs) used for the prevascularization process of bone constructs.
The majority of articles are focused on regenerative medicine applications such as improvement on
bioprinted cartilage [52], orthopedics [53–55], bone tissue bioprinting [56], prevascularization on bone
tissue constructs [57] and cartilage tissue engineering [58,59]. One of the indirect contributions to the
regenerative medicine field would be the study of a reversible cross-linking strategy [60]. In Table 2,
there is only one example of human chondrocytes with a PEGDA hydrogel [51], which could be an
isolated case because the articles that use primary chondrocytes are combined with alginate-based
and/or gelatin methacryloyl hydrogels. There is also a lack of information on three articles about the
cell lines used, which could help to determine if there is a relationship between the cell lines used and
the compounds of their hydrogels.
2.3.3. Cardiac Tissues
The principal applications for cardiac tissue engineering are reported in Table 3, mainly focused
on 3D-Bioplotter™ and with only one example of another brand of 3D bioprinter. The applications are
focused on the generation of tissue spheroids [61], regenerative medicine for the generation of cardiac
patches [62], cardiac implants, and nano-reinforced cardiac patches’ [63].
For 3D-Bioplotter™, human cardiac progenitor cells (hCPCs) and human coronary artery
endothelial tissues became used for regenerative medicine applications, combined with alginate-based
hydrogel or gelatin methacrylate hydrogel, then supplemented with support materials such as cardiac
extracellular matrix, PEI, calcium chloride, methacrylated collagen, and carboxyl functionalized carbon
nanotubes (CNTs).
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Table 2. Principal cartilage and bone applications.
3D Printer Used Cell Line (s) Used Materials Used Applications Reference
Modified HP® Deskjet
500 printer
Human chondrocytes PEGDA 1 hydrogel Ambiguous [51]
Multihead deposition
system (MHDS) printer
from AM technology
Not specified Alginate-based ink completedwith PCL 2
Strength improvement on
bioprinted cartilage [52]
3D printer Not specified PCL/hydroxyapatite hydrogel Orthopaedic applications [32,34,53,54]
Biological laser (BioLP)
printer designed in the
laboratory
Not specified Alginate/hydroxyapatitehydrogel Orthopedic applications [55]
3D-Bioplotter™ BMSCs 3
Non-medical alginate hydrogel
and calcium chloride/Lutrol
F127/Matrigel/Agarose and
methylcellulose
Patterned constructs for bone
tissue bioprinting [56]
3D-Bioplotter™ SVFC 4 PCL/hydroxyapatite hydrogel
Prevascularization in 3D
bioprinted bone constructs [57]
3D-Bioplotter™ Primary chondrocytes, other cells Alginate hydrogel, PCL andcalcium chloride Cartilage tissue engineering [58]
3D-Bioplotter™ Primary chondrocytes Alginate/hydroxyapatitehydrogel Cartilage tissue engineering [59]
3D-Bioplotter™
Primary chondrocytes,
Mesenchymal stem cells,
Cartilage derived progenitor cells
Gelatin methacryloyl hydrogel,
with a photoinitiator
Reversible cross-linking strategy
on cartilage tissue engineering [60]
1 poly(ethylene glycol) diacrylate. 2 polycaprolactone. 3 bone marrow stromal cells. 4 endothelial stromal cells derived from the stromal vascular fraction of adipose tissue.
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Table 3. Principal cardiac tissue applications.
3D Printer Used Cell Line (s) Used Materials Used Applications Reference
Printer designed by
nScrypt Inc.
Cardiac cells and
HUVEC 1 Not specified
Tissue
spheroids [61]
3D-Bioplotter™ hCPCs 2
Gelatin methacrylate
hydrogel and cardiac
ECM 3
Cardiac patches [62]
3D-Bioplotter™
Human coronary
artery endothelial
tissues
Alginate hydrogel
and calcium
chloride/PEI 4
Cardiac
implants [63]
3D-Bioplotter™ Human coronaryartery endothelial cells
Alginate hydrogel
and methacrylated
collagen and CNTs 5
Nano-reinforced
cardiac patches [63]
1 human umbilical vein endothelial cells. 2 human cardiac progenitor cells. 3 extracellular matrix.
4 polyethyleneimine. 5 carboxyl functionalized carbon nanotubes.
2.3.4. Liver Tissues
For liver tissue applications, exposed in Table 4, there are only two examples of each type
of 3D bioprinter. In the case of Organovo 3D-bioprinter, there is no information about the cell
lines and materials used [64], which make the comparison of the two types of bioprinters difficult.
The only described example is the use of 3D-Bioplotter™ for the bioprinting of liver tissue using a
decellularized extracellular matrix of the liver and a sacrificial material called Pluronic F-127, combined
with immortalized mouse small cholangiocytes and a cancer cell line called HUH7 [65].
Table 4. Principal liver tissue applications.
3D Printer Used Cell Line (s) Used Materials Used Applications Reference
Organovo
3D-bioprinter Not specified
Not specified (with
problems)
Microliver tissues for
in vitro drug testing [64]
3D-Bioplotter™
Immortalized
mouse small
cholangiocytes and
HUH7 1
dECM 2 of the liver
and sacrificial material
(Pluronic F-127)
3D-Bioprinting for
liver tissues [65]
1 human hepatocellular carcinoma cell line. 2 decellularized extracellular matrix.
2.3.5. Stem Cells
In the subject of stem cell applications, the majority of the papers use an alginate-based hydrogel
with only three examples of methacrylated gelatin hydrogels combined [66–70], as reflected in Table 5.
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Table 5. Principal stem cell applications.
3D Printer Used Cell Line (s) Used Materials Used Applications Reference
3D-Bioplotter™ iPSCs 1 and/or hNSCs 2 Alginate-CMC 3 hydrogel Tissue bioprinting [60]
3D-Bioplotter™ iPSCs Alginate-CMC-agarose hydrogel andcalcium chloride
In situ cell proliferation and
successive multilineage
differentiation
[66]
3D-Bioplotter™ ASMCs 4
Complex hydrogel (methacrylated
hyaluronic acid, methacrylated gelatin,
hyaluronic acid and gelatin
Breast cancer model for drug
resistance study [67]
3D-Bioplotter™ Human mesenchymal stem cells Methacrylated gelatin hydrogel Placenta model forpreeclampsia [69]
3D-Bioplotter™ Frontal cortical human neuralstem cells
Alginate-CMC-agarose hydrogel and
calcium chloride
Human neural tissues’
applications [60]
3D-Bioplotter™ Frontal cortical human neuralstem cells
Alginate-CMC-agarose hydrogel and
calcium chloride
Production of neural
mini-tissues [60]
3D-Bioplotter™ Human mesenchymal stem cellsand L929 fibroblasts
Gelatin methacrylate hydrogel/alginate
hydrogel and calcium chloride
Mesoscopic fluorescence
tomography for bone tissue
engineering
[70]
3D-Bioplotter™ hASCs 5 Alginate hydrogel and calcium chloride
Monitoring of 3D constructs via
dielectric impedance
spectroscopy technique
[68]
3D-Bioplotter™ Human adipose-derivedmesenchymal stem cells Sodium alginate-gelatin hydrogel
Osteogenesis’ applications on
in vivo studies [71]
1 induced-pluripotent stem cells. 2 human neural stem cells. 3 carboxymethyl-chitosan. 4 adipose-derived mesenchymal stem/stromal cells. 5 human adipose-derived stem cells.
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There is also a clear relationship between cell lines and hydrogel compositions, in some cases.
This can be observed with iPS and neural stem cells that use an alginate hydrogel supplemented
with carboxymethyl-chitosan and agarose, with human mesenchymal stem cells for containing
methacrylated gelatin as one component of their respective hydrogels [69,70]. The majority of
applications are related to regenerative medicine such as the production of neural mini-tissues [60] but
also related to model development for drug testing and the study of diseases such as breast cancer [67]
and preeclampsia [69]. Only two examples are related to the development of techniques such as
dielectric impedance spectroscopy technique [68] and mesoscopic fluorescence tomography [70].
2.3.6. Cancer Cells
Principal cancer cell applications are represented in Table 6. Alginate is the main component of
the hydrogels, followed by methacrylated gelatin and a complex hydrogel formulation [67].
Table 6. Principal cancer cell applications.
3D Printer Used Cell line (s) Used Materials Used Applications Reference
3D-Bioplotter™ 21PT cell line 1
Complex hydrogel
(methacrylated hyaluronic
acid, methacrylated gelatin,
hyaluronic acid and gelatin
Breast cancer model for drug
resistance study [67]
3D-Bioplotter™ SaOS-2 cell line 2
Biocalcite hydrogel (alginate
and biosilica)
Synthesis of calcium
phosphate-bone [72]
3D-Bioplotter™
HUH7 3 and
immortalized mouse
small cholangiocytes
dECM 4 of the liver and
sacrificial material (Pluronic
F-127)
3D-Bioprinting for liver
tissues [65]
3D-Bioplotter™ SaOS-2 cell line
Alginate-gelatin-bioglass
hydrogel, polyP/calcium
chloride, and silica/biosilica
Growth and
biomineralization of SaOS-2
cells on bioglass
[72]
3D-Bioplotter™ SaOS-2 cell line
Alginate-gelatin-agarose
hydrogel and calcium
chloride
Bioprinting of bioartificial
tissue [73]
3D-Bioplotter™ MG63 cell line
5 and
hASCs 6
Alginate hydrogel and
calcium chloride
Monitoring of 3D constructs
via dielectric impedance
spectroscopy technique
[68]
3D-Bioplotter™ HepG2 7
Methacrylated gelatin
B-type photocurable with
UV-light
Constructs with high cell
viability [74]
3D-Bioplotter™ ATDC5 8 Alginate hydrogel and PCL 9 Cartilage tissue engineering [58]
3D-Bioplotter™ ATDC5
Alginate-hyaluronic acid
hydrogel and calcium
chloride or PVA 10 or PEI 11
Tissue reparation [75]
3D-Bioplotter™ ATDC5 Alginate hydrogel and PCLand calcium chloride
Cartilage tissues’
applications [76]
3D-Bioplotter™ JEG3 cell line
12 and
trophoblast cells
Methacrylated gelatin
hydrogel and EGF 13
Testing on ZEB2, a master
regulator of EMT 14 [77]
1 HER2 -positive breast tumour cell line. 2 sarcoma osteogenic cell line. 3 hepatocellular carcinoma cell line.
4 decellularized extracellular matrix. 5 osteosarcoma cell line. 6 human adipose-derived stem cells. 7 hepatocarcinoma
cell line. 8 mouse teratocarcinoma cell line. 9 polycaprolactone. 10 poly(vinyl alcohol). 11 polyethyleneimine.
12 choriocarcinoma cell line. 13 epidermal growth factor. 14 epithelial-mesenchymal transition.
The applications are related to regenerative and other medical studies but only is associated
with cancer study, which in that case is drug testing using an HER-2 positive breast cancer cell line
called 21PT, combined with a complex hydrogel based on methacrylated gelatin supplemented with
other compounds [67]. One interesting study would be the one associated with the biofabrication of
constructs with high cell viability because the authors performed a photo-crosslinking technique with
a UV light source that apparently does not affect the cell viability of the scaffold [74].
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2.3.7. Adipose Tissues
In the matter of adipose tissue applications, only two examples are found in Table 7 that use
methacrylated gelatin-based hydrogels. Only one example is related to regenerative medicine on
adipose tissue engineering, with supplementation of PEG-4A in the hydrogel [50]. The other application
is related to the metabolic study for the differences between white and brown adipose tissues [57].
Table 7. Principal adipose tissue applications.
3D Printer Used Cell Line (s) Used Materials Used Applications Reference
3D-Bioplotter™ WAP 1 and BAP 2
Methacrylated
hyaluronic
acid-methacrylated
gelatin and hyaluronic
acid and gelatin
Checking
behaviour and
metabolic function
on human brown
adipocyte
[57]
3D-Bioplotter™ HWA
3 and
HUVEC 4
Methacrylated gelatin,
methacrylated
hyaluronic acid, and
PEG-4A 5
Robust cryogel for
adipose tissue
engineering
[50]
1 human white adipose progenitor cells. 2 human brown adipose progenitor cells. 3 human adipose progenitor cells.
4 human umbilical vein endothelial cells. 5 4arm poly(ethylene glycol) acrylate.
2.3.8. Muscle Cells
For muscle cells, there is only one application that uses L8 myoblasts and Schwann cells, combined
with an alginate-based hydrogel for a study of cell damages of bioprinting processes [78], seen in
Table 8.
Table 8. Muscle cell application, for 3D-Bioplotter™ technology.
3D Printer Used Cell Line (s) Used Materials Used Applications Reference
3D-Bioplotter™ L8 myoblasts andSchwann cells
Alginate hydrogel
and DMEM 1
Characterization of
cell damage and
proliferative ability
during and after
bioprinting
[78]
1 Dulbecco’s modified eagle medium.
2.3.9. Schwann Cells
Concerning Schwann cell applications, the main component of the hydrogels employed is alginate,
supplemented with different support materials depending on the cell line and resulted applications.
Some applications the development of better peptide-modified alginate scaffolds [79], the repair of
peripheral nerve injury [80], production of scaffolds with high integrity and cell viability [81], and the
explanation of cell damage and proliferative ability on bioprinting processes [78]. Further information
can be found in Table 9.
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Table 9. Principal Schwann cell applications.
3D Printer Used Cell Line (s) Used Materials Used Applications Reference
3D-Bioplotter™ Living Schwanncells
Alginate/RGD
1-alginate hydrogel,
hyaluronic acid,
fibrinogen, and
calcium chloride
Potential nerve tissue
engineering
applications
[78]
3D-Bioplotter™ Rat primarySchwann cells
Alginate hydrogel,
RGD/YIGSR 2 peptides,
and calcium
chloride/PEI 3
Peptide-modified
alginate scaffolds [79]
3D-Bioplotter™ RSC96 cell line 4
Alginate hydrogel,
hyaluronic acid, and
calcium chloride
Scaffolds with high
integrity and cell
viability
[81]
3D-Bioplotter™ RSC96 cell line andL8 myoblasts
Alginate hydrogel and
DMEM 5
Characterization of cell
damage and
proliferative ability
during and after
bioprinting
[78]
3D-Bioplotter™ RSC96 cell line Alginate hydrogel andcalcium chloride/PEI
Repair of peripheral
nerve injury [80]
3D-Bioplotter™ Rat Schwann cellsand ATDC5 6
Alginate-hyaluronic
acid hydrogel and
calcium chloride/PVA 7
or PEI 8
Tissue reparation [75]
1 arginine-glycine-aspartate peptide. 2 tyrosine-isoleucine-glycine-serine-arginine peptide. 3 polyethyleneimine. 4
ATTC immortalized rat Schwann cell line. 5 Dulbecco’s modified eagle medium. 6 mouse teratocarcinoma cell line.
7 poly(vinyl alcohol). 8 polyethyleneimine.
2.3.10. Skin Tissues
Relative to skin tissue applications (Table 10) almost all hydrogels use methacrylated gelatin
followed by PEG formulations and a novel hydrogel formulation. One interesting article is the
proposed alternative hydrogel formulation based on lignin, which is suggested as a new concept for
skin tissue bioprinting. The majority of the papers correspond to regenerative medicine, except for one
on the use of mesoscopic fluorescence tomography, previously mentioned [70]. Except for the novel
formulation [82], it seems that the common cross-linking method used is the chemical one, exempting
the use of a photoinitiator and tyrosinase on bioprinting of living skin tissue constructs [83].
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Table 10. Principal skin tissue applications.
3D Printer Used Cell Line (s) Used Materials Used Applications Reference
3D-Bioplotter™ HDF 1 and HUVEC 2
35 formulations of PEG
3-X polymers
Cell-compatible
hydrogels [49]
3D-Bioplotter™
L929 fibroblasts and
Human mesenchymal
stem cells
Gelatin methacrylate
hydrogel/alginate
hydrogel and calcium
chloride
Mesoscopic
fluorescence
tomography for
bone tissue
engineering
[70]
3D-Bioplotter™ NIH/3T3 cell line 4
Methacrylated gelatin
hydrogel and EGF 5
Regenerative
medicine for
tympanic
membrane
perforations
[69]
3D-Bioplotter™ Primary humandermal fibroblast cells
Lignin—HPU 6
hydrogel
A new concept for
fibroblasts
bioprinting
[82]
3D-Bioplotter™ HEM
7, HaCat 8,
and HDF
Gelatin
methacrylamide
hydrogel, collagen,
and photoinitiator (and
tyrosinase)
Bioprinting of
living skin
constructs
[83]
1 human dermal fibroblasts. 2 human umbilical vein endothelial cells. 3 poly(ethylene glycol). 4 murine fibroblast
cell line. 5 epidermal growth factor. 6 hydrophilic polyurethane. 7 human melanocytes. 8 human keratinocytes.
2.4. General Summary
The main and support materials used for bioprinting can be seen in Figures 3 and 4, obtained
from a revision of the literature of 40 articles on bioprinting tests with the 3D-Bioplotter™.
As seen in Figure 3, the most common material used for scaffold manufacturing is alginate.
Alginate is a good candidate because it is cheap, easy to print, to handle and extrude while protecting
encapsulated cells within it [84]. It has limits such as the absence of cell-adhesion properties [85],
but they can be avoided by adding gelatin [86], hyaluronic acid [75], or methacrylated collagen [63] as
support materials.
As for the scaffold geometry, there is not a clear default geometry because it depends on the type
of bio-inks used and the authors and the final applications in each case. As previously said, alginate is
an interesting material to be used for bioprinting, not only because it is cheap but also because of its
high biocompatibility and the ability to absorb water, and therefore the ability to control cell viability
within the hydrogel [87,88].
One of the main issues in 3D bioprinting is to maintain the cell viability because many factors
such as shear stress during printing and cell encapsulation could reduce the cell growth from 40% to
2% and that cell damage may also be caused by the different cross-linking processes performed after
bioprinting [89]. Materials by themselves, like alginate, have some limitations that might influence the
cell viability during bioprinting, so the combination with support materials could be helpful to reduce
these problems [90]. For example, the combination of alginate and biosilica resulted in being more
promising not only for the bone tissue culture formation than alginate or biosilica alone, but also for the
cell viability due to the improved extrusion process [72]. Other authors proposed the use of cylindrical
cell aggregates, composed of mouse bone marrow cells (BMSC), Schwann cells (SC) and agarose, to not
only make it easy to handle the bio-ink but also not affecting the generation of the proper post-printing
structure because of a reduction on the cell damage [91]. When the main application is regenerative
medicine and transplants, an autograft of adult stem cells, especially adipose-derived stem cells, can
be used safely to avoid the rejection process during transplantation [92].
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Other improvements can be made for mechanical properties such as mechanical strength, elasticity,
and stiffness. Some of the strategies can be, for example, the cross-linking methods by exposure to
ultraviolet light, heat, and/or an ionic solution.
Figure 3. Main materials used for scaffolds bioprinting. The information is represented as
percentages (%).
Figure 4. Support materials used for scaffolds. The information is represented as percentages (%).
3. Manufacturing Parameters
3.1. Temperature of the Head and Plate
This relationship is the most uncertain, firstly because the process temperatures are mostly related
to the bioprinted materials and due to the lack of information on the temperature of the head and plate
of the 3D-Bioplotter™, among the different papers consulted.
Most of the articles only contain one of those two parameters (57.5%) and only a small portion of
the research (5%) includes all the available information to understand the possible correlation between
them. The majority of the papers report a temperature of the head and the plate around 22 ◦C while
printing alginate or methacrylated gelatin-based hydrogels in the presence of cells. A high portion of
papers gives no indications on those parameters, which have a strong relationship with the cell survival
rate in the synthesized constructs. While the temperature of the head is more related to the cells’
viability and the material properties, the temperature of the plate could be a crucial parameter because
the plate is involved in processes like physical cross-linking and the maintenance of cell viability
post-printing. The temperature information could be beneficial especially when newly developed
materials are used.
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3.2. Pressure
Pressure is an important parameter to be considered, not only because every polymer has its
specific properties such as viscosity among others, but also because, when the printing is performed
with cells, they need to be maintained all of the time in the optimal conditions because a stress situation
provoked, for example, by higher pressures might be capable of altering the viability of the cells,
and reducing it, which can be a problem for the experiments that are being performed. In Table 11,
we can see some examples of different cell lines from bone and cartilage tissues, stem cells, cancer cells,
adipose tissues, Schwann cells related to the nervous system and fibroblasts, in this order.
Table 11. Some examples of different pressures applied to different cell types constructs, using a
3D-Bioplotter™ printer. All the pressures are expressed in kilopascals (kPa), to improve the comparison
between articles.
Cell Line (s) Pressure (kPa) References
BMSCs 1 30–300 [56]
Primary chondrocytes (cartilage tissue) 10 [59]
hCPCs 2 70–80 [62]
Human iPSCs 3 5 [66]
ASMCs 4 300–350 [67]
hNSCs 5 150–200 [60]
ATDC5 6 30 [58]
SaOS-2 cell line 7 90 [72,73]
21PT cell line 8 300–350 [67]
HWA 9 (+HUVEC 10) 300–350 [50]
Living Schwann cells 30 [78]
HDF 11 (+HUVEC) 100–250 [49]
Primary human dermal fibroblasts 200 [82]
1 bone marrow stromal cells. 2 human cardiac progenitor cells. 3 induced-pluripotent stem cells. 4 adipose-derived
mesenchymal stem/stromal cells. 5 human neural stem cells. 6 mouse teratocarcinoma cell line. 7 sarcoma osteogenic
cell line. 8 HER2 -positive breast tumour cell line. 9 human adipose progenitor cell line. 10 human umbilical vein
endothelial cells. 11 human dermal fibroblasts.
4. Applications of Bioprinting
The applications of bioprinting can be classified by their field, such as regenerative medicine,
material science, drug testing, and other (i.e., cellular characterization). As illustrated in Figure 5,
the main application in 3D bioprinting is regenerative medicine (37.5%). Some examples could
be those related to the production of implants for cardiac failure, audition-loss [62,69], cartilage
tissue engineering [58,93], and human neural tissue construction [7]. According to the analyzed
literature, drug tests are mainly related to the design of cellular models for clinical research.
Apropos of material science and other advanced applications, some examples are those related to
cell-compatible hydrogel synthesis [27], improvements on cell viability maintenance during bioprinting
processes [68], and the development of new materials such as a combination between lignin and
polyurethane [82]. Other examples related to the medical field, classified as other applications,
are cellular characterization [94], chemical material characterization [95], development of new
techniques [70,76], and gene characterization [77].
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Figure 5. Classification of applications for the 3D-Bioplotter™ printer. All of the available information
is classified into five categories, and the results are expressed as percentages (%).
5. Discussion
As previously mentioned, different materials and systems can be used for 3D bioprinting, and
especially for regenerative medicine. Focusing on 3D-Bioplotter™ systems, the main material used for
scaffold manufacturing is alginate, but combined with other polymers in order to improve its mechanic
and biologic properties. One of the possible improvements is the use of polyethyleneimine (PEI) as a
chemical cross-linking, in order to improve the mechanical stability of the 3D constructs [80,81].
Furthermore, 37.5% of the analyzed articles do not have clear temperature information and that is
very crucial for the maintenance of cell viability because variations of those parameters can increase
cell viability and, therefore, affect the validation of experiments in the 3D bioprinting field.
Furthermore, a new field derived from 3D bioprinting was introduced recently, called 4D
bioprinting. The main difference between 3D and 4D bioprinting is that this latest technology uses
smart materials that can re-shape in the response to external stimuli such as light, temperature, and
humidity [96]. This new technology uses the same 3D printers but with different materials, so it is an
improvement in the material science side. All the smart materials must fulfill the same properties as the
biomaterials used in 3D bioprinting, such as biocompatibility, non-inflammatory response, dynamic
and supporting physiological functions [97], non-toxicity, and with appropriate rheological properties
if needed [98].
Thus, even though 3D bioprinting was established 17 years ago, there are still some limitations
on the manufacturing processes as well as on the availability of bio-inks on the market, to mimic
more exactly the natural cell microenvironment. Further studies might be developed to improve the
fabrication of tissue-engineered scaffolds [83]. In the future, it will be necessary for the development of
high-resolution multi-material bioprinters and accurate stimulation methods to be used not only in a
regenerative medicine field but also in research in general, in order to find new biomarkers on more
diseases or disorders, and help treat them more effectively.
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